Key Moments
410 ‒ The biology of pregnancy: physiologic adaptation, childbirth, and long-term maternal health
Key Moments
Pregnancy is a severe physiologic stressor that can unmask underlying health issues, with complications like preeclampsia and gestational diabetes predicting long-term cardiovascular and metabolic disease.
Key Insights
Plasma volume can increase by 50% by 28 weeks of pregnancy, leading to a relative anemia and significant cardiovascular stress.
Gestational diabetes screening occurs between 24-28 weeks, and 50% of women diagnosed with it will develop type 2 diabetes later in life.
Preeclampsia, characterized by new-onset hypertension and proteinuria after 20 weeks gestation, affects about 5-7% of pregnancies and significantly increases long-term cardiovascular disease risk.
While many stillbirths remain unexplained even after extensive testing, common contributing factors include placental insufficiency and fetal growth restriction.
Self-free DNA screening (NIPT) has dramatically improved the sensitivity and specificity for screening chromosomal disorders like Down syndrome, reducing the need for invasive procedures like amniocentesis.
Pregnancy research remains an underfunded and neglected area, despite its profound impact on maternal and child health across the lifespan.
Pregnancy as an extreme physiologic stress test
Pregnancy imposes immense physiological demands on the mother, essentially acting as a severe stress test for her cardiovascular and metabolic systems. Plasma volume expands dramatically, increasing by up to 50% by 28 weeks, which can strain the heart and lungs, potentially unmasking underlying conditions. This expansion also leads to a relative anemia. Furthermore, the body develops increased insulin resistance, particularly in the second half of pregnancy, which can lead to gestational diabetes in susceptible individuals. This process can reveal predispositions to various diseases that may not have been apparent before pregnancy. The speaker notes that it's remarkable the species has propagated given these challenges, highlighting the profound adaptations required.
Endocrine shifts and early pregnancy changes
Early in pregnancy, the ovaries support the developing fetus by producing estradiol and progesterone. Around 8-10 weeks, the placenta takes over hormone production. Human chorionic gonadotropin (hCG) rises dramatically from conception, though its exact role in early pregnancy symptoms like nausea is not fully understood, with recent insights pointing to the GDF-15 gene in hyperemesis gravidarum. While morning sickness can be severe, the primary maternal risks are dehydration and malnutrition. Standard antiemetics can be used, but often medical intervention, including IV hydration and nutrition, is required for severe cases, affecting less than 1% of pregnancies.
The second trimester: fetal growth and metabolic adaptation
The second trimester is characterized by significant fetal growth, accompanied by an acceleration in plasma volume expansion. Maternal metabolism shifts towards increased insulin resistance, a process considered adaptive to ensure adequate fuel for the fetus. However, this can lead to gestational diabetes in some women. Routine screening for gestational diabetes between 24-28 weeks became standard because risk factors alone missed half of affected individuals. Uncontrolled gestational diabetes can lead to fetal macrosomia, increased risk of preeclampsia, and complications at delivery. Importantly, it also confers a higher long-term risk for the child developing metabolic issues.
Gestational diabetes diagnosis and management
Diagnosis of gestational diabetes involves a one-hour glucose challenge test (50g glucose load), followed by a three-hour oral glucose tolerance test if the initial screen is elevated. First-line treatment focuses on dietary modifications and glucose monitoring. If lifestyle changes are insufficient, insulin is typically the first-line medication, rather than oral agents like metformin, due to concerns about safety data and efficacy in pregnancy. While Metformin is considered relatively safe, insulin offers the best neonatal outcomes. Gestational diabetes usually resolves after delivery, but affected women are recommended for postpartum screening for type 2 diabetes, as 50% will develop it later in life.
Preeclampsia: a pregnancy-specific hypertensive disorder
Preeclampsia is a serious condition defined by new-onset hypertension (systolic ≥ 140 or diastolic ≥ 105-110 mmHg) after 20 weeks gestation, often with proteinuria or other severe features. It affects about 5-7% of pregnancies, with higher risks in first pregnancies and in women who are very young or over 40. The underlying mechanism involves an angiogenic imbalance, where the placenta releases anti-angiogenic factors that damage maternal blood vessel endothelium and kidney glomeruli. Left untreated, preeclampsia can lead to seizures, stroke, and organ failure. While anti-hypertensives can manage blood pressure, delivery of the placenta is the only cure. Early onset (before 34 weeks) is particularly risky, requiring careful balancing of maternal and fetal risks for delivery timing.
HELLP syndrome and the genetic underpinnings of preeclampsia
HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets) is a severe variant of preeclampsia, though its exact biological relationship is debated. It presents with overlapping features, including severe hypertension and significant lab abnormalities. Delivery is typically expedited in cases of HELLP syndrome. Preeclampsia has a clear genetic component, influenced by both maternal and fetal/placental genetics. Recent genome-wide association studies have identified shared genetic architectures with essential hypertension, suggesting that pregnancy may unmask an underlying genetic predisposition to high blood pressure. The pregnancy itself may also contribute to long-term cardiovascular risk.
Neural tube defects and the importance of folic acid
Folic acid supplementation prior to conception is crucial to prevent neural tube defects (NTDs) in the fetus. NTDs, such as myelomeningocele, occur when the neural tube doesn't close properly, potentially leading to lifelong disabilities affecting motor function, bowel, and bladder control. In rare, severe cases like anencephaly, the brain and cranium do not form. While in-utero surgery can help some cases of myelomeningocele, the exact cause of NTDs is not fully understood, with both genetic and sporadic factors involved. Despite preventative measures, NTDs are still seen, with referral centers diagnosing cases monthly.
Delivery modes and fetal monitoring
Cesarean section rates have increased significantly over the past 50 years, now reaching around 30% in many academic centers. This rise is attributed to various factors, including increased pregnancy risk, a higher likelihood of repeat C-sections after a prior one, and the use of continuous fetal monitoring during labor, which can lead to interventions for non-reassuring fetal heart rate tracings. While C-sections are life-saving, concerns exist regarding risks in future pregnancies, such as placenta accreta, and uterine rupture, especially with classical C-section incisions. Breech presentations are generally managed with C-sections due to the risk of head entrapment, although external cephalic versions can sometimes turn the baby. The overall stillbirth rate in the US is about 1 in 160 pregnancies after 20 weeks, with many causes remaining unexplained even after thorough investigation.
Postpartum health and mental well-being
Postpartum 'baby blues' are common due to the dramatic drop in estrogen and progesterone after delivery, but persistent depressive symptoms constitute postpartum depression. Screening for depression is recommended during pregnancy and postpartum. Challenges in treatment include limited access to mental health services, time constraints for new mothers, and societal pressure to feel happy, leading to underreporting and undertreatment. While breastfeeding offers benefits, most women can physiologically produce milk, though complexities arise with premature infants or personal circumstances impacting the ability to sustain it. The lactational amenorrhea method is not a reliable form of contraception.
Prenatal screening and the evolving landscape of genetic testing
Non-invasive prenatal screening using cell-free DNA (cfDNA) from maternal blood has largely replaced older serum screening methods for chromosomal disorders like trisomies 21, 18, and 13, and fetal sex, as early as 9-10 weeks. This test offers high sensitivity and specificity, reducing the need for diagnostic procedures like amniocentesis. However, cfDNA screening covers only a fraction of potential genetic conditions. There's a significant gap between technological capabilities for whole-genome sequencing and the established framework for screening, counseling, and cost-effectiveness, particularly for inborn errors of metabolism that may not have prenatal ultrasound markers.
Long-term maternal health implications and research gaps
Pregnancy unmasks vulnerabilities that predict future health. Gestational diabetes confers a 50% risk of developing type 2 diabetes, and preeclampsia significantly increases the long-term risk of cardiovascular disease. Despite the critical role of pregnancy in a woman's health trajectory, research in this area remains underfunded and neglected, even at the NIH. There is a need for greater investment to develop new interventions and treatments. The US healthcare system's complexity, including inconsistent insurance coverage and high costs, further complicates maternal care and long-term follow-up, impacting overall maternal and infant health outcomes.
Mentioned in This Episode
●Supplements
●Software & Apps
●Organizations
●Drugs & Medications
●Concepts
●People Referenced
Common Questions
Dr. Katie Markham is a physician-scientist with an MD and a PhD in immunology. She specializes in obstetrics and gynecology, drawn to women's health and the many unanswered questions in pregnancy research.
Topics
Mentioned in this video
Recommended for increased nutrient demands during pregnancy, especially for folic acid and iron.
A class of drugs; a novel benzodiazepine derivative was studied by Katie Markham during her PhD for its role in treating autoimmune lupus and later for inflammatory bowel disease.
A hormone important for maintaining uterine quiescence and supporting placental development during pregnancy.
The dominant estrogen produced by the ovary in early pregnancy.
Essential vitamin to have adequate levels of prior to conception to reduce the risk of neural tube defects.
A class of anti-hypertensive drugs known to be unsafe in pregnancy due to negative fetal impact.
Given in cases like HELLP syndrome to help mature a baby's lungs, allowing for earlier delivery if needed.
Human Chorionic Gonadotropin, a hormone that increases dramatically in early pregnancy.
An anti-hypertensive agent commonly used in pregnancy for preeclampsia due to good safety data.
An anti-hypertensive agent commonly used in pregnancy for preeclampsia due to good safety data.
A medication considered fairly safe and potentially helpful in pregnancy for gestational diabetes, but insulin is generally preferred as first-line.
First-line treatment for gestational diabetes when dietary modifications are insufficient, due to its effectiveness and safety data for neonatal outcomes.
A hormone that can be administered to help induce or augment labor.
A class of anti-hypertensive drugs known to be unsafe in pregnancy due to negative fetal impact.
Host of The Drive podcast.
Guest on The Drive podcast, a physician-scientist (MD PhD) specializing in obstetrics and gynecology.
Researcher at Harvard known for work on anti-VEGF for cancer, providing a connection to the angiogenic factors discussed in preeclampsia.
The specific target of the novel benzodiazepine that Katie Markham investigated during her PhD.
An anti-angiogenic factor released by a hypoxic placenta in preeclampsia, which soaks up VEGF, affecting maternal and kidney endothelial cells.
The field in which Katie Markham received her PhD.
A gene flagged as important in driving hyperemesis gravidarum based on genetic studies, now a developing target for therapeutics.
An antibody important in breast milk, providing immunity to the baby.
The underlying physiological cause of hypertension and proteinuria in preeclampsia, involving abnormal placental trophoblast invasion.
A procedure to manually turn a breech baby to a head-down position before labor, with a 50% success rate.
Tools that have helped improve communication of patient medical history, including obstetric history, to primary care providers.
Standard screening method for gestational diabetes, typically done between 24-28 weeks of pregnancy.
An invasive diagnostic procedure that has decreased in frequency due to advancements in non-invasive screening methods.
An invasive diagnostic procedure that can be done earlier in pregnancy than amniocentesis.
Where Katie Markham attended undergrad and had an advisory meeting that influenced her to pursue an MD PhD.
The NIH branch that funds most pregnancy-related research, though its name doesn't explicitly mention pregnancy.
Professional organization that provides recommendations, such as generally not attempting vaginal delivery for breech babies.
A federal agency noted for underfunding pregnancy research, despite its importance.
Medical institution where nephrologist Anant Kuramomani conducted research on preeclampsia.
More from Peter Attia MD
View all 346 summaries
156 min409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles
140 min407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and more
77 minBlood pressure: how to measure, manage, and treat high blood pressure (AMA #48 rebroadcast)
130 min406 ‒ Migraine, cluster headache, and tension headache: symptoms, causes, prevention, and treatment
Ask anything from this episode.
Save it, chat with it, and connect it to Claude or ChatGPT. Get cited answers from the actual content — and build your own knowledge base of every podcast and video you care about.
Get Started Free